Enable your JavaScript to use Numstock


Numstock » ACHN

ACHN Stock Analysis

The latest metrics for Achillion Pharmaceuticals, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -12.23
Price / Book Value Ratio < 1.5 4.02
Price / Sales Ratio < 2.0 0.0
PEG Ratio < 1.0 -0.37
EV / EBITDA Ratio < 8.0 -9.15
Price / FCF Ratio Last Year < 15.0 -11.57
Price / FCF Ratio Last Quarter < 15.0 -41.39
Price / TBV Ratio Last Year < 0.7 3.24
Price / TBV Ratio Last Quarter < 0.7 4.03
Price / NCAV Ratio Last Year < 0.7 3.27
Price / NCAV Ratio Last Quarter < 0.7 6.31

Efficiency

Metric Target Value
ROE Last Year > 25.0% -23.8
ROE Last Quarter > 25.0% -8.73
ROA Last Year > 15.0% -25.29
ROA Last Quarter > 15.0% -8.29
ROTA Last Year > 20.0% -31.32
ROTA Last Quarter > 20.0% -8.91
ROIC Last Year > 20.0% -27.05
ROIC Last Quarter > 20.0% -9.58
ROCE Last Year > 20.0% -27.82
ROCE Last Quarter > 20.0% -9.38
Inventory Turnover Last Year > 4.0 0.0
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% 0.0
Pre-tax Margin Last Quarter > 20.0% 0.0
Accounts Payable Turnover Last Year > 3.0 21.46
Accounts Payable Turnover Last Quarter > 3.0 4.77
Accounts Receivable Turnover Last Year > 5.0 30.19
Accounts Receivable Turnover Last Quarter > 5.0 9.03

Health

Metric Target Value
Current Ratio Last Year > 1.5 23.28
Current Ratio Last Quarter > 1.5 13.34
Quick Ratio Last Year > 1.5 23.28
Quick Ratio Last Quarter > 1.5 13.34
Flow Ratio Last Year < 1.25 19.28
Flow Ratio Last Quarter < 1.25 9.66
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 2056
Interest Coverage Ratio Last Quarter > 8.0 10527
FCF / Sales Ratio Last Year > 8.0% 0.0
FCF / Sales Ratio Last Quarter > 8.0% 0.0

Growth

Metric Target Value
Earnings Yield > 12% -8.18
Ebit Yield Last Year > 12% -8.84
Ebit Yield Last Quarter > 12% -2.47
FCF Yield Last Year > 10% -7.14
FCF Yield Last Quarter > 10% -1.89
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.88
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.23

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -1.27
Altman Z-score Last Quarter ≥ 3.5 -1.66